Chester County News and Community Website
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS), a Pennsylvania-based clinical-stage drug platform company, has announced the completion of the last patient visit in the phase II/III study of its …
Annovis Bio Wraps Up Phase II/III Trial for Alzheimer’s Drug Buntanetap Read More
BALA CYNWYD, PA — The clinical-stage biotech firm Larimar Therapeutics has reported promising top-line data from its Phase 2 dose exploration study. The groundbreaking study tested the medication ‘nomlabofusp’ on …
Pioneering Leap for Friedreich’s Ataxia Treatment: Larimar Therapeutics Announces Encouraging Phase 2 Results for Nomlabofusp Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced initial positive results from a pilot study of its pain management drug candidate, Probudur™. The study was conducted under an …
Virpax Pharmaceuticals Reports Promising Results in Probudur Pilot Study Read More
RADNOR, PA — Pennsylvania-based biopharmaceutical company NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced a significant development in its ongoing clinical trial for a novel treatment for bipolar depression. The company …
NRx Pharmaceuticals Completes Enrollment for Bipolar Depression Trial, Eyes Q2 Readout Read More
SPRING HOUSE, PA — Johnson & Johnson recently announced that its investigational drug, nipocalimab, has received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA). The designation …
FDA Grants Breakthrough Therapy Status to Johnson & Johnson’s Nipocalimab for HDFN Treatment Read More SPRING HOUSE, PA — In a remarkable breakthrough for the healthcare industry, Johnson & Johnson’s investigational targeted oral peptide, JNJ-2113, has displayed positive results in a Phase 2b study for …
Promising Breakthrough in Psoriasis Treatment: Johnson & Johnson’s JNJ-2113 Achieves Stellar Results Read More
KING OF PRUSSIA, PA — Global biotech leaders CSL and Arcturus Therapeutics have released the results of a six-month follow-up analysis comparing their self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine, ARCT-154, …
CSL’s ARCT-154 Vaccine Outperforms Comirnaty in Six-Month COVID-19 Study Read More SPRING HOUSE, PA — Johnson & Johnson has recently revealed encouraging results from trials of nipocalimab, a new drug that could offer hope to adults suffering from generalized myasthenia gravis …
Johnson & Johnson’s Nipocalimab Shows Promise in Treating Rare Autoantibody Diseases Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals (NASDAQ: MDGL) recently took a significant stride towards introducing the first treatment for Nonalcoholic Steatohepatitis (NASH) with liver fibrosis. The drug, resmetirom, has cleared a …
Breakthrough in Liver Disease Treatments: Madrigal’s Resmetirom Aims to Be the First Approved NASH Therapy Read More
GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a pioneering international research initiative, committing over $500,000 to two multiyear projects aimed at developing treatments for the most prevalent demyelinating …
New Research Initiative Targets Common Forms of Charcot-Marie-Tooth Disease Read More